Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid - Wikidata - awgldk - TriplyDB

Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid

Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid

http://www.wikidata.org/entity/Q36753126

about

Analysis of pleiotropic transcriptional profiles: a case study of DNA gyrase inhibition Campylobacter and fluoroquinolones: a bias data set?Do we need an intravenous fluoroquinolone?gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae.Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility.A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics.Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli.Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro.Quinolone accumulation in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus.Reduced susceptibilities of Shigella sonnei strains isolated from patients with dysentery to fluoroquinolones.Characterization of clinical isolates of Escherichia coli showing high levels of fluoroquinolone resistance The use of platensimycin and platencin to fight antibiotic resistance.Development and validation of a diagnostic DNA microarray to detect quinolone-resistant Escherichia coli among clinical isolates.Novel ciprofloxacin-resistant, nalidixic acid-susceptible mutant of Staphylococcus aureus.Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility.Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid.Mechanism of action of sparfloxacin against and mechanism of resistance in gram-negative and gram-positive bacteria.Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to GyrA and ParC mutations.Inactivation of efflux pumps abolishes bacterial biofilm formation.Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates.Bacteremia due to fluoroquinolone-resistant Escherichia coli in two immunocompromised patients.

P2860

Q28469049-AB9D2FE2-B8AB-479A-8FDE-CC7525960323 Q30781159-1567036C-EC61-4A1A-BB60-B0550CAD9560 Q33606570-7F167353-BD47-4AE9-AF08-C00B72B44262 Q33699643-BE0E1D1A-E4B5-47D8-87E3-E87DFC9E7D82 Q33752287-7CA6EB9D-DEC3-4A70-AAAD-7BAE4FC66100 Q33762110-871927FF-80CB-4F0B-A82A-5B718CEB2DE8 Q34010692-D8E6803D-EBB0-4696-8E3C-CD6E845C5196 Q34143901-A886D620-3A5F-459D-AE1C-A3BEB4640E78 Q35131092-1DADD5F0-6BF3-4DCE-B100-78A01CC37D0B Q35811107-0A62E442-2B8E-4C76-B335-6794C0FEB544 Q35821472-20EBB48E-7FCE-411D-BF10-E6EED2C09A3D Q35893473-EBC1F978-AEB6-47B6-830A-886CABA2DF6F Q35900349-79C6BA86-1900-47C0-92C4-8101E26529BA Q36528206-8C6CDC9A-22E3-42B1-B50A-5E050C63B266 Q37203095-9C6FB033-B189-4A69-BC9E-0FC1ECE18EFD Q37511160-239910D1-59C8-4E23-99D7-3B309209AABB Q39652276-3E8FA529-2E0B-449E-A456-6F909A4161A0 Q39652979-A44C8F72-3E64-49C1-9877-66EEE1B30F27 Q39866134-913EB431-1FBB-41DE-BD34-9C4343F42B4C Q40088128-40645400-4A0D-4B86-A31F-7C8B4741C6F4 Q40638334-54A081E7-4179-4074-8844-C71ADC39F095 Q41385683-56581E31-9A02-4F99-BEC5-1BF32F26AE0B Q54069730-BBAF151F-3C82-4C7A-A56D-A2155C524DFD Q54216093-2C2E25D5-EC8E-4E83-A645-C226D2410161

P2860

Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid

http://www.wikidata.org/entity/Q36753126

description

1991 nî lūn-bûn

@nan

1991年の論文

@ja

1991年論文

@yue

1991年論文

@zh-hant

1991年論文

@zh-hk

1991年論文

@zh-mo

1991年論文

@zh-tw

1991年论文

@wuu

1991年论文

@zh

1991年论文

@zh-cn

name

Mechanisms of quinolone resist ...... susceptible to nalidixic acid

@en

type

label

Mechanisms of quinolone resist ...... susceptible to nalidixic acid

@en

prefLabel

Mechanisms of quinolone resist ...... susceptible to nalidixic acid

@en

P1433

Q36753126-1B950E78-4605-421E-B291-9AD81DD833AA

P1476

Q36753126-9CE947F4-230E-42BE-BA7E-AFB3581284C6

P2093

Q36753126-0F5F47A7-5421-4FBD-9786-B5499FB1677C

Q36753126-4A434E6A-72E4-4EA2-A536-6E5AA1FC0A41

Q36753126-A8207A67-D4E3-4CEF-B725-DB773400F7EE

Q36753126-CB75EF3E-D4FD-437F-9847-AC9213E79686

Q36753126-E04290D1-C481-454B-8334-08F21576DB25

Q36753126-FD4DE287-3479-4E5F-9E5D-BEF8A8AEEC55

P2860

Q36753126-09E79404-3DE7-4C24-AB6F-3A44E02DE760

Q36753126-10E802C4-43A5-4E8A-8013-57B0A0DC31BF

Q36753126-13DC9CF7-25A2-4896-BBAD-F20C0CF65A0D

Q36753126-29A70D3B-7357-4DC1-B81A-02CAE3245B97

Q36753126-322F912F-8360-4DC9-9242-C0F4FF60394F

Q36753126-4A457061-C29A-458B-B36F-DB5B6C8A61C9

Q36753126-4D500D43-744E-479F-A542-7D0ECD05C630

Q36753126-636E4BEB-3DCC-44DE-BE8F-C355B508948F

Q36753126-65D20CB9-7F61-4951-B2F9-7112EA089B91

Q36753126-7621D1EC-A810-4872-B5AA-131A39D3465A

P304

Q36753126-501FD812-CDCC-477D-86BA-05CD0E99C9EB

P31

Q36753126-9AF9B72D-BC26-448A-BA13-092A00F6CFFB

P356

Q36753126-7CB3FA2D-1FAA-4B54-BFBB-EACA6B7011F9

P407

Q36753126-E1E5AF24-7673-4FC1-8706-5177AAF42DC4

P433

Q36753126-8BD87508-3C52-4378-9EBB-6F797FAD785A

P478

Q36753126-A6B39C41-EC6D-4765-BEE8-DA5E710039EB

P577

Q36753126-3E177EBB-0A65-4A6D-A834-634C9143C8FB

P5875

Q36753126-7C49B714-E406-4FA9-AA39-B716DFCFCF4E

P698

Q36753126-5DF6B0A3-3CA4-467D-8560-31C716F76798

P921

Q36753126-BE1A7C78-9BFC-44F2-93F7-DD8FFB4BEF69

P932

Q36753126-21951229-E1E1-452E-A35C-D6E69AD104A1

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Mechanisms of quinolone resist ...... susceptible to nalidixic acid

@en

P2093

Acar JF

http://www.w3.org/2001/XMLSchema#string

Collatz E

http://www.w3.org/2001/XMLSchema#string

Guibert J

http://www.w3.org/2001/XMLSchema#string

Gutmann L

http://www.w3.org/2001/XMLSchema#string

Moniot-Ville N

http://www.w3.org/2001/XMLSchema#string

Moreau N

http://www.w3.org/2001/XMLSchema#string

P2860

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Properties of the penicillin-binding proteins of Escherichia coli K12,

Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation.

Association between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF) acrA] Escherichia coli K-12

Endogenous active efflux of norfloxacin in susceptible Escherichia coli

Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels

Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.

Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies

Mechanisms of action of and resistance to ciprofloxacin.

Fluorometric assay for fleroxacin uptake by bacterial cells.

P304

519-523

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.35.3.519

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

1991-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21117214

http://www.w3.org/2001/XMLSchema#string

P698

2039202

http://www.w3.org/2001/XMLSchema#string

P921

P932

245042

http://www.w3.org/2001/XMLSchema#string